Article info
PDFOriginal Article
Clinical Science
Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements
- Correspondence to Dr L V Del Priore, 635 West 165th Street, New York, NY 10032, USA; ldelpriore{at}yahoo.com
Citation
Duration of action of intravitreal ranibizumab and bevacizumab in exudative AMD eyes based on macular volume measurements
Publication history
- Accepted March 2, 2009
- First published May 7, 2009.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd. All rights reserved.